Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Prostatic Neoplasms"" wg kryterium: Temat


Tytuł :
Quantitative Prostate MRI.
Autorzy :
Schieda N; Department of Medical Imaging, The Ottawa Hospital, Ottawa, Ontario, Canada.
Lim CS; Department of Medical Imaging, Sunnybrook Health Sciences, Toronto, Ontario, Canada.
Zabihollahy F; Faculty of Engineering, Carleton University, Ottawa, Ontario, Canada.
Abreu-Gomez J; Department of Medical Imaging, Sunnybrook Health Sciences, Toronto, Ontario, Canada.
Krishna S; Joint Department of Medical Imaging, University Health Network, Toronto, Ontario, Canada.
Woo S; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Melkus G; Department of Medical Imaging, The Ottawa Hospital, Ottawa, Ontario, Canada.
Ukwatta E; Faculty of Engineering, Guelph University, Guelph, Ontario, Canada.
Turkbey B; Molecular Imaging Program, National Cancer Institute NIH, Bethesda, Maryland, USA.
Pokaż więcej
Źródło :
Journal of magnetic resonance imaging : JMRI [J Magn Reson Imaging] 2021 Jun; Vol. 53 (6), pp. 1632-1645. Date of Electronic Publication: 2020 May 15.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Magnetic Resonance Imaging*
Prostatic Neoplasms*/diagnostic imaging
Diffusion Magnetic Resonance Imaging ; Humans ; Male ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Response to letter: Multiparametric magnetic resonance imaging in patients with nonalcoholic fatty liver disease.
Autorzy :
Schaapman JJ; Department of Radiology, Leiden University Medical Center, Leiden, The Netherlands.; Department of Gastroenterology and Hepatology, Leiden University Medical Center, Leiden, The Netherlands.
Coenraad MJ; Department of Gastroenterology and Hepatology, Leiden University Medical Center, Leiden, The Netherlands.
Lamb HJ; Department of Radiology, Leiden University Medical Center, Leiden, The Netherlands.
Pokaż więcej
Źródło :
Journal of magnetic resonance imaging : JMRI [J Magn Reson Imaging] 2021 Jun; Vol. 53 (6), pp. 1941. Date of Electronic Publication: 2021 Jan 12.
Typ publikacji :
Letter
MeSH Terms :
Elasticity Imaging Techniques*
Multiparametric Magnetic Resonance Imaging*
Non-alcoholic Fatty Liver Disease*/diagnostic imaging
Prostatic Neoplasms*
Humans ; Liver/diagnostic imaging ; Magnetic Resonance Imaging ; Male
Opinia redakcyjna
Tytuł :
Ancillary imaging and clinical features for the characterization of prostate lesions: A proposed approach to reduce false positives.
Autorzy :
Lee CM; Department of Radiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
Park KJ; Department of Radiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
Kim MH; Department of Radiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
Kim JK; Department of Radiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
Pokaż więcej
Źródło :
Journal of magnetic resonance imaging : JMRI [J Magn Reson Imaging] 2021 Jun; Vol. 53 (6), pp. 1887-1897. Date of Electronic Publication: 2020 Dec 29.
Typ publikacji :
Journal Article
MeSH Terms :
Magnetic Resonance Imaging*
Prostatic Neoplasms*/diagnostic imaging
Biopsy ; Humans ; Male ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Diagnostic nomogram based on intralesional and perilesional radiomics features and clinical factors of clinically significant prostate cancer.
Autorzy :
Zhang H; School of Medical Imaging, Binzhou Medical University, Yantai, China.; Department of Radiology, Yantai Yuhuangding Hospital, Qingdao University, Yantai, China.
Li X; School of Medical Imaging, Binzhou Medical University, Yantai, China.
Zhang Y; Department of Radiology, Yantai Yuhuangding Hospital, Qingdao University, Yantai, China.
Huang C; Department of Radiology, Zhifu Branch of Yantai Yuhuangding Hospital (Yantai Zhifu Hospital), Yantai, China.
Wang Y; Department of Urology, Yantai Yuhuangding Hospital, Qingdao University, Yantai, China.
Yang P; Department of Pathology, Yantai Yuhuangding Hospital, Qingdao University, Yantai, China.
Duan S; GE Healthcare, Shanghai, China.
Mao N; Department of Radiology, Yantai Yuhuangding Hospital, Qingdao University, Yantai, China.
Xie H; Department of Radiology, Yantai Yuhuangding Hospital, Qingdao University, Yantai, China.
Pokaż więcej
Źródło :
Journal of magnetic resonance imaging : JMRI [J Magn Reson Imaging] 2021 May; Vol. 53 (5), pp. 1550-1558.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Nomograms*
Prostatic Neoplasms*/diagnostic imaging
Humans ; Magnetic Resonance Imaging ; Male ; Retrospective Studies ; Tumor Microenvironment
Czasopismo naukowe
Tytuł :
Optimized MRI Assessment for Clinically Significant Prostate Cancer: A STARD-Compliant Two-Center Study.
Autorzy :
Bao J; Department of Radiology, The First Affiliated Hospital of Soochow University, Suzhou, China.
Zhi R; Department of Radiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Hou Y; Department of Radiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Zhang J; Department of Radiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Wu CJ; Department of Radiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Wang XM; Department of Radiology, The First Affiliated Hospital of Soochow University, Suzhou, China.
Zhang YD; Department of Radiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Pokaż więcej
Źródło :
Journal of magnetic resonance imaging : JMRI [J Magn Reson Imaging] 2021 Apr; Vol. 53 (4), pp. 1210-1219. Date of Electronic Publication: 2020 Oct 19.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Prostatic Neoplasms*/diagnostic imaging
Diffusion Magnetic Resonance Imaging ; Humans ; Magnetic Resonance Imaging ; Male ; Prostatectomy ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Neuroendocrine differentiation in usual-type prostatic adenocarcinoma: Molecular characterization and clinical significance.
Autorzy :
Kaur H; Department of Pathology, School of Medicine, Johns Hopkins University, Baltimore, Maryland.
Samarska I; Department of Pathology, School of Medicine, Johns Hopkins University, Baltimore, Maryland.
Lu J; Department of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland.
Faisal F; Department of Urology, School of Medicine, Johns Hopkins University, Baltimore, Maryland.
Maughan BL; Department of Oncology, School of Medicine, Johns Hopkins University, Baltimore, Maryland.; Division of Medical Oncology, Huntsman Cancer Institute, The University of Utah, Salt Lake City, Utah.
Murali S; Department of Pathology, School of Medicine, Johns Hopkins University, Baltimore, Maryland.
Asrani K; Department of Pathology, School of Medicine, Johns Hopkins University, Baltimore, Maryland.
Alshalalfa M; Division of Bioinformatics, GenomeDx Biosciences, Vancouver, Canada.
Antonarakis ES; Department of Oncology, School of Medicine, Johns Hopkins University, Baltimore, Maryland.
Epstein JI; Department of Pathology, School of Medicine, Johns Hopkins University, Baltimore, Maryland.; Department of Urology, School of Medicine, Johns Hopkins University, Baltimore, Maryland.; Department of Oncology, School of Medicine, Johns Hopkins University, Baltimore, Maryland.
Joshu CE; Department of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland.
Schaeffer EM; Department of Urology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois.
Mosquera JM; Department of Pathology, Weill Cornell Medicine, New York, New York.
Lotan TL; Department of Pathology, School of Medicine, Johns Hopkins University, Baltimore, Maryland.; Department of Urology, School of Medicine, Johns Hopkins University, Baltimore, Maryland.; Department of Oncology, School of Medicine, Johns Hopkins University, Baltimore, Maryland.
Pokaż więcej
Źródło :
The Prostate [Prostate] 2020 Sep; Vol. 80 (12), pp. 1012-1023. Date of Electronic Publication: 2020 Jul 10.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms :
Neuroendocrine Cells/*pathology
Neuroendocrine Tumors/*pathology
Prostatic Neoplasms/*pathology
Adenocarcinoma/genetics ; Adenocarcinoma/metabolism ; Adenocarcinoma/pathology ; Carcinoma, Small Cell/genetics ; Carcinoma, Small Cell/metabolism ; Carcinoma, Small Cell/pathology ; Cell Differentiation/physiology ; Cohort Studies ; Humans ; Immunohistochemistry ; Male ; Middle Aged ; Neuroendocrine Cells/metabolism ; Neuroendocrine Tumors/genetics ; Neuroendocrine Tumors/metabolism ; PTEN Phosphohydrolase/genetics ; PTEN Phosphohydrolase/metabolism ; Prostatic Neoplasms/genetics ; Prostatic Neoplasms/metabolism ; Prostatic Neoplasms, Castration-Resistant/genetics ; Prostatic Neoplasms, Castration-Resistant/pathology ; Receptors, Androgen/biosynthesis ; Receptors, Androgen/genetics ; Receptors, Androgen/metabolism ; Retinoblastoma Binding Proteins/genetics ; Retinoblastoma Binding Proteins/metabolism ; Retrospective Studies ; Signal Transduction ; Tumor Suppressor Protein p53/genetics ; Tumor Suppressor Protein p53/metabolism ; Ubiquitin-Protein Ligases/genetics ; Ubiquitin-Protein Ligases/metabolism
Czasopismo naukowe
Tytuł :
Can ultrasound irradiation be a therapeutic option for prostate cancer?
Autorzy :
Maeshige N; Department of Rehabilitation Science, Kobe University Graduate School of Health Science, Kobe, Japan.; John B. Little Center for Radiation Sciences, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
Kitagawa K; Department of Advanced Medical Science, Kobe University Graduate School of Science, Technology and Innovation, Kobe, Japan.; Department of International Health, Kobe University Graduate School of Health Sciences, Kobe, Japan.
Yamasaki S; Department of International Health, Kobe University Graduate School of Health Sciences, Kobe, Japan.
Ishii A; Department of International Health, Kobe University Graduate School of Health Sciences, Kobe, Japan.
Shirakawa T; Department of Advanced Medical Science, Kobe University Graduate School of Science, Technology and Innovation, Kobe, Japan.; Department of International Health, Kobe University Graduate School of Health Sciences, Kobe, Japan.
Yang YM; Department of Urology, Kobe University Graduate School of Medicine, Kobe, Japan.
Sung SY; The Ph.D. Program for Translational Medicine, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan.
Chen KC; Department of Urology, Taipei Medical University-Shuang Ho Hospital, Taipei, Taiwan.
Yuan ZM; John B. Little Center for Radiation Sciences, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
Shigemura K; Department of International Health, Kobe University Graduate School of Health Sciences, Kobe, Japan.; Department of Urology, Kobe University Graduate School of Medicine, Kobe, Japan.
Fujisawa M; Department of Urology, Kobe University Graduate School of Medicine, Kobe, Japan.
Pokaż więcej
Źródło :
The Prostate [Prostate] 2020 Sep; Vol. 80 (12), pp. 986-992. Date of Electronic Publication: 2020 Jun 18.
Typ publikacji :
Journal Article
MeSH Terms :
Prostatic Neoplasms/*radiotherapy
Ultrasonic Therapy/*methods
Apoptosis/radiation effects ; Cell Line, Tumor ; Cell Proliferation/radiation effects ; Cell Survival/radiation effects ; Humans ; Male ; PC-3 Cells ; Prostatic Neoplasms/pathology ; Prostatic Neoplasms, Castration-Resistant/pathology ; Prostatic Neoplasms, Castration-Resistant/radiotherapy
Czasopismo naukowe
Tytuł :
Impact of DNA damage repair defects and aggressive variant features on response to carboplatin-based chemotherapy in metastatic castration-resistant prostate cancer.
Autorzy :
Slootbeek PHJ; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.
Duizer ML; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.
van der Doelen MJ; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.; Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands.
Kloots ISH; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.
Kuppen MCP; Institute for Medical Technology Assessment (iMTA), Erasmus School of Health Policy and Management, Erasmus University Rotterdam, Rotterdam, The Netherlands.
Westgeest HM; Department of Internal Medicine, Amphia Hospital, Breda, The Netherlands.
Uyl-de Groot CA; Institute for Medical Technology Assessment (iMTA), Erasmus School of Health Policy and Management, Erasmus University Rotterdam, Rotterdam, The Netherlands.
Pamidimarri Naga S; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.; Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.
Ligtenberg MJL; Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.; Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands.
van Oort IM; Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands.
Gerritsen WR; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.
Schalken JA; Department of Experimental Urology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.
Kroeze LI; Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands.
Bloemendal HJ; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.
Mehra N; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.
Pokaż więcej
Źródło :
International journal of cancer [Int J Cancer] 2021 Jan 15; Vol. 148 (2), pp. 385-395. Date of Electronic Publication: 2020 Oct 03.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
DNA Repair*
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Prostatic Neoplasms, Castration-Resistant/*drug therapy
Prostatic Neoplasms, Castration-Resistant/*genetics
Aged ; BRCA2 Protein/genetics ; Carboplatin/administration & dosage ; DNA Damage ; Drug Resistance, Neoplasm ; Germ-Line Mutation ; Humans ; Kaplan-Meier Estimate ; Male ; Neoplasm Staging ; Netherlands/epidemiology ; Poly(ADP-ribose) Polymerase Inhibitors/administration & dosage ; Prostatic Neoplasms, Castration-Resistant/mortality ; Prostatic Neoplasms, Castration-Resistant/pathology ; Retrospective Studies ; Taxoids/administration & dosage ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Androgen receptor signaling-targeted therapy and taxane chemotherapy induce visceral metastasis in castration-resistant prostate cancer.
Autorzy :
Iwamoto H; Department of Integrative Cancer Therapy and Urology, Graduate School of Medical Science, Kanazawa University, Kanazawa, Ishikawa, Japan.
Izumi K; Department of Integrative Cancer Therapy and Urology, Graduate School of Medical Science, Kanazawa University, Kanazawa, Ishikawa, Japan.
Shimada T; Department of Integrative Cancer Therapy and Urology, Graduate School of Medical Science, Kanazawa University, Kanazawa, Ishikawa, Japan.
Kano H; Department of Integrative Cancer Therapy and Urology, Graduate School of Medical Science, Kanazawa University, Kanazawa, Ishikawa, Japan.
Kadomoto S; Department of Integrative Cancer Therapy and Urology, Graduate School of Medical Science, Kanazawa University, Kanazawa, Ishikawa, Japan.
Makino T; Department of Integrative Cancer Therapy and Urology, Graduate School of Medical Science, Kanazawa University, Kanazawa, Ishikawa, Japan.
Naito R; Department of Integrative Cancer Therapy and Urology, Graduate School of Medical Science, Kanazawa University, Kanazawa, Ishikawa, Japan.
Yaegashi H; Department of Integrative Cancer Therapy and Urology, Graduate School of Medical Science, Kanazawa University, Kanazawa, Ishikawa, Japan.
Shigehara K; Department of Integrative Cancer Therapy and Urology, Graduate School of Medical Science, Kanazawa University, Kanazawa, Ishikawa, Japan.
Kadono Y; Department of Integrative Cancer Therapy and Urology, Graduate School of Medical Science, Kanazawa University, Kanazawa, Ishikawa, Japan.
Mizokami A; Department of Integrative Cancer Therapy and Urology, Graduate School of Medical Science, Kanazawa University, Kanazawa, Ishikawa, Japan.
Pokaż więcej
Źródło :
The Prostate [Prostate] 2021 Jan; Vol. 81 (1), pp. 72-80. Date of Electronic Publication: 2020 Oct 13.
Typ publikacji :
Journal Article
MeSH Terms :
Prostatic Neoplasms, Castration-Resistant/*drug therapy
Prostatic Neoplasms, Castration-Resistant/*metabolism
Receptors, Androgen/*metabolism
Aged ; Aged, 80 and over ; Androstenes/therapeutic use ; Docetaxel/therapeutic use ; Humans ; Incidence ; Lung Neoplasms/secondary ; Male ; Middle Aged ; Neoplasm Metastasis ; Neoplasm Staging ; Phenylthiohydantoin/analogs & derivatives ; Phenylthiohydantoin/therapeutic use ; Prostatic Neoplasms, Castration-Resistant/epidemiology ; Prostatic Neoplasms, Castration-Resistant/pathology ; Retrospective Studies ; Risk Factors ; Signal Transduction/drug effects ; Taxoids/therapeutic use
Czasopismo naukowe
Tytuł :
A phase II randomized placebo-controlled trial of pomegranate fruit extract in men with localized prostate cancer undergoing active surveillance.
Autorzy :
Jarrard D; Department of Urology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.; Environmental and Molecular Toxicology Program, University of Wisconsin, Madison, Wisconsin, USA.; University of Wisconsin Carbone Cancer Center, Madison, Wisconsin, USA.
Filon M; Department of Urology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.
Huang W; University of Wisconsin Carbone Cancer Center, Madison, Wisconsin, USA.; Department of Pathology and Laboratory Medicine, University of Wisconsin, Madison, Wisconsin, USA.
Havighurst T; Department of Biostatistics and Medical Informatics, University of Wisconsin, Madison, Wisconsin, USA.
DeShong K; University of Wisconsin Carbone Cancer Center, Madison, Wisconsin, USA.
Kim K; University of Wisconsin Carbone Cancer Center, Madison, Wisconsin, USA.; Department of Biostatistics and Medical Informatics, University of Wisconsin, Madison, Wisconsin, USA.
Konety BR; Department of Urology, University of Minnesota, Minneapolis, Minnesota, USA.
Saltzstein D; Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.
Mukhtar H; University of Wisconsin Carbone Cancer Center, Madison, Wisconsin, USA.; Department of Dermatology, School of Medicine and Public Health, University of Wisconsin, Wisconsin.
Wollmer B; University of Wisconsin Carbone Cancer Center, Madison, Wisconsin, USA.
Suen C; National Cancer Institute, Bethesda, Maryland, USA.
House MG; National Cancer Institute, Bethesda, Maryland, USA.
Parnes HL; National Cancer Institute, Bethesda, Maryland, USA.
Bailey HH; University of Wisconsin Carbone Cancer Center, Madison, Wisconsin, USA.; Urology San Antonio Research, University of Wisconsin-Madison, Madison, Wisconsin.
Pokaż więcej
Źródło :
The Prostate [Prostate] 2021 Jan; Vol. 81 (1), pp. 41-49. Date of Electronic Publication: 2020 Oct 23.
Typ publikacji :
Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural
MeSH Terms :
Antineoplastic Agents, Phytogenic/*administration & dosage
Plant Extracts/*administration & dosage
Pomegranate/*chemistry
Prostatic Neoplasms/*drug therapy
Biomarkers, Tumor/blood ; Biomarkers, Tumor/urine ; Biopsy ; Fruit/chemistry ; Humans ; Insulin-Like Growth Factor Binding Protein 3/blood ; Insulin-Like Growth Factor I/metabolism ; Kallikreins/blood ; Male ; Middle Aged ; Phytotherapy ; Placebos ; Plant Extracts/isolation & purification ; Prostate-Specific Antigen/blood ; Prostatic Neoplasms/blood ; Prostatic Neoplasms/pathology ; Prostatic Neoplasms/urine ; Watchful Waiting
Czasopismo naukowe
Tytuł :
Neuropeptide Y nerve paracrine regulation of prostate cancer oncogenesis and therapy resistance.
Autorzy :
Ding Y; Department of Pathology and Laboratory Medicine, McGovern School of Medicine, University of Texas Health Sciences Center Medical School, Houston, Texas, USA.
Lee M; Biostatistics, Epidemiology, and Research Design (BERD) Core, Department of Internal Medicine, University of Texas Health Sciences Center Medical School, Houston, Texas, USA.
Gao Y; Department of Pathology and Laboratory Medicine, McGovern School of Medicine, University of Texas Health Sciences Center Medical School, Houston, Texas, USA.
Bu P; Department of Pathology and Laboratory Medicine, McGovern School of Medicine, University of Texas Health Sciences Center Medical School, Houston, Texas, USA.
Coarfa C; Department of Molecular & Cell Biology, Baylor College of Medicine, Houston, Texas, USA.
Miles B; Department of Urology, The Methodist Hospital, Houston, Texas, USA.
Sreekumar A; Department of Pathology and Laboratory Medicine, McGovern School of Medicine, University of Texas Health Sciences Center Medical School, Houston, Texas, USA.
Creighton CJ; Department of Internal Medicine, Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, Texas, USA.
Ayala G; Biostatistics, Epidemiology, and Research Design (BERD) Core, Department of Internal Medicine, University of Texas Health Sciences Center Medical School, Houston, Texas, USA.
Pokaż więcej
Źródło :
The Prostate [Prostate] 2021 Jan; Vol. 81 (1), pp. 58-71. Date of Electronic Publication: 2020 Oct 06.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Neuropeptide Y/*metabolism
Prostatic Neoplasms/*radiotherapy
Adolescent ; Adult ; Age Factors ; Animals ; Apoptosis/radiation effects ; Axons/metabolism ; Axons/radiation effects ; Botulinum Toxins, Type A/pharmacology ; Carcinogenesis ; Cell Line, Tumor ; Child ; Humans ; Male ; Metabolome ; Mice ; Middle Aged ; NF-kappa B/metabolism ; Nervous System/metabolism ; Nervous System/pathology ; Nervous System/radiation effects ; Neuropeptide Y/antagonists & inhibitors ; Prostatic Neoplasms/genetics ; Prostatic Neoplasms/metabolism ; Radiation Tolerance ; Transcriptome ; Young Adult
Czasopismo naukowe
Tytuł :
The 26th Annual Prostate Cancer Foundation Scientific Retreat Report.
Autorzy :
Miyahira AK; Science Department, Prostate Cancer Foundation, Santa Monica, California, USA.
Soule HR; Science Department, Prostate Cancer Foundation, Santa Monica, California, USA.
Pokaż więcej
Źródło :
The Prostate [Prostate] 2021 Jan; Vol. 81 (1), pp. 3-19. Date of Electronic Publication: 2020 Oct 21.
Typ publikacji :
Congress
MeSH Terms :
Prostatic Neoplasms/*therapy
Animals ; Humans ; Immunotherapy ; Male ; Molecular Targeted Therapy ; Prostatic Neoplasms/genetics ; Prostatic Neoplasms/metabolism ; Prostatic Neoplasms/pathology ; Randomized Controlled Trials as Topic
Tytuł :
High intratumoral CD8 T-cell infiltration is associated with improved survival in prostate cancer patients undergoing radical prostatectomy.
Autorzy :
Yang Y; Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA.; Division of Medical Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, USA.
Attwood K; Department of Biostatistics and Bioinformatics, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA.
Bshara W; Department of Pathology, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA.
Mohler JL; Department of Urology, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA.
Guru K; Department of Urology, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA.
Xu B; Department of Pathology, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA.
Kalinski P; Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA.
Chatta G; Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA.
Pokaż więcej
Źródło :
The Prostate [Prostate] 2021 Jan; Vol. 81 (1), pp. 20-28. Date of Electronic Publication: 2020 Oct 21.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms :
CD8-Positive T-Lymphocytes/*immunology
Lymphocytes, Tumor-Infiltrating/*immunology
Prostatic Neoplasms/*immunology
Adult ; Aged ; CD8-Positive T-Lymphocytes/pathology ; Cohort Studies ; Humans ; Lymphocytes, Tumor-Infiltrating/pathology ; Male ; Middle Aged ; Multivariate Analysis ; Neoplasm Staging ; Prognosis ; Prostatectomy ; Prostatic Neoplasms/mortality ; Prostatic Neoplasms/surgery ; Retrospective Studies ; Survival Rate
Czasopismo naukowe
Tytuł :
Improved Characterization of Diffusion in Normal and Cancerous Prostate Tissue Through Optimization of Multicompartmental Signal Models.
Autorzy :
Conlin CC; Department of Radiology, UC San Diego School of Medicine, La Jolla, California, USA.
Feng CH; Department of Radiation Medicine and Applied Sciences, UC San Diego School of Medicine, La Jolla, California, USA.
Rodriguez-Soto AE; Department of Radiology, UC San Diego School of Medicine, La Jolla, California, USA.
Karunamuni RA; Department of Radiation Medicine and Applied Sciences, UC San Diego School of Medicine, La Jolla, California, USA.
Kuperman JM; Department of Radiology, UC San Diego School of Medicine, La Jolla, California, USA.
Holland D; Department of Neurosciences, UC San Diego School of Medicine, La Jolla, California, USA.
Rakow-Penner R; Department of Radiology, UC San Diego School of Medicine, La Jolla, California, USA.
Hahn ME; Department of Radiology, UC San Diego School of Medicine, La Jolla, California, USA.
Seibert TM; Department of Radiology, UC San Diego School of Medicine, La Jolla, California, USA.; Department of Radiation Medicine and Applied Sciences, UC San Diego School of Medicine, La Jolla, California, USA.; Department of Bioengineering, UC San Diego Jacobs School of Engineering, La Jolla, California, USA.
Dale AM; Department of Radiology, UC San Diego School of Medicine, La Jolla, California, USA.; Department of Neurosciences, UC San Diego School of Medicine, La Jolla, California, USA.; Halıcıoğlu Data Science Institute, UC San Diego, La Jolla, California, USA.
Pokaż więcej
Źródło :
Journal of magnetic resonance imaging : JMRI [J Magn Reson Imaging] 2021 Feb; Vol. 53 (2), pp. 628-639. Date of Electronic Publication: 2020 Oct 31.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms :
Prostatic Neoplasms*/diagnostic imaging
Bayes Theorem ; Diffusion Magnetic Resonance Imaging ; Humans ; Male ; Reproducibility of Results ; Retrospective Studies
Czasopismo naukowe
Tytuł :
GRB10 sustains AR activity by interacting with PP2A in prostate cancer cells.
Autorzy :
Hao J; Vancouver Prostate Centre, Department of Urologic Sciences, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.; Department of Experimental Therapeutics, BC Cancer Agency, Vancouver, British Columbia, Canada.
Ci X; Vancouver Prostate Centre, Department of Urologic Sciences, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.; Department of Experimental Therapeutics, BC Cancer Agency, Vancouver, British Columbia, Canada.
Wang Y; Vancouver Prostate Centre, Department of Urologic Sciences, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.; Department of Urology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, China.
Choi SYC; Vancouver Prostate Centre, Department of Urologic Sciences, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.; Department of Experimental Therapeutics, BC Cancer Agency, Vancouver, British Columbia, Canada.
Sullivan SE; Vancouver Prostate Centre, Department of Urologic Sciences, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.; Department of Kinesiology and Physical Education, McGill University, Quebec, Canada.
Xue H; Department of Experimental Therapeutics, BC Cancer Agency, Vancouver, British Columbia, Canada.
Wu R; Department of Experimental Therapeutics, BC Cancer Agency, Vancouver, British Columbia, Canada.
Dong X; Department of Experimental Therapeutics, BC Cancer Agency, Vancouver, British Columbia, Canada.
Haegert AM; Vancouver Prostate Centre, Department of Urologic Sciences, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
Collins CC; Vancouver Prostate Centre, Department of Urologic Sciences, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
Lin D; Vancouver Prostate Centre, Department of Urologic Sciences, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.; Department of Experimental Therapeutics, BC Cancer Agency, Vancouver, British Columbia, Canada.
Wang Y; Vancouver Prostate Centre, Department of Urologic Sciences, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.; Department of Experimental Therapeutics, BC Cancer Agency, Vancouver, British Columbia, Canada.
Pokaż więcej
Źródło :
International journal of cancer [Int J Cancer] 2021 Jan 15; Vol. 148 (2), pp. 469-480. Date of Electronic Publication: 2020 Oct 21.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
GRB10 Adaptor Protein/*metabolism
Prostatic Neoplasms/*metabolism
Protein Phosphatase 2/*metabolism
Receptors, Androgen/*metabolism
Animals ; Cell Line, Tumor ; GRB10 Adaptor Protein/genetics ; Gene Knockdown Techniques ; HEK293 Cells ; Heterografts ; Humans ; Male ; Mice ; Prostatic Neoplasms/genetics ; Protein Phosphatase 2/antagonists & inhibitors ; Signal Transduction
Czasopismo naukowe
Tytuł :
Contrast Medium or No Contrast Medium for Prostate Cancer Diagnosis. That Is the Question.
Autorzy :
Padhani AR; Paul Strickland Scanner Centre, Mount Vernon Cancer Centre, Northwood, UK.
Schoots I; Department of Radiology & Nuclear Medicine, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
Villeirs G; Department of Radiology, Ghent University Hospital, Ghent, Belgium.
Pokaż więcej
Źródło :
Journal of magnetic resonance imaging : JMRI [J Magn Reson Imaging] 2021 Jan; Vol. 53 (1), pp. 13-22. Date of Electronic Publication: 2020 May 03.
Typ publikacji :
Journal Article
MeSH Terms :
Multiparametric Magnetic Resonance Imaging*
Prostatic Neoplasms*/diagnostic imaging
Humans ; Magnetic Resonance Imaging ; Male ; Prospective Studies
Czasopismo naukowe
Tytuł :
CHD1 and SPOP synergistically protect prostate epithelial cells from DNA damage.
Autorzy :
Zhu Y; Department of Biological Sciences, Boler-Parseghian Center for Rare and Neglected Diseases, Harper Cancer Research Institute, University of Notre Dame, Notre Dame, Indiana, USA.; Integrated Biomedical Sciences Graduate Program, University of Notre Dame, Notre Dame, Indiana, USA.
Wen J; Department of Biological Sciences, Boler-Parseghian Center for Rare and Neglected Diseases, Harper Cancer Research Institute, University of Notre Dame, Notre Dame, Indiana, USA.; Department of Urology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China.
Huang G; Department of Biological Sciences, Boler-Parseghian Center for Rare and Neglected Diseases, Harper Cancer Research Institute, University of Notre Dame, Notre Dame, Indiana, USA.; Department of Urology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China.
Mittlesteadt J; Department of Biological Sciences, Boler-Parseghian Center for Rare and Neglected Diseases, Harper Cancer Research Institute, University of Notre Dame, Notre Dame, Indiana, USA.
Wen X; Department of Urology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China.
Lu X; Department of Biological Sciences, Boler-Parseghian Center for Rare and Neglected Diseases, Harper Cancer Research Institute, University of Notre Dame, Notre Dame, Indiana, USA.; Integrated Biomedical Sciences Graduate Program, University of Notre Dame, Notre Dame, Indiana, USA.; Tumor Microenvironment and Metastasis Program, Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, Indiana, USA.
Pokaż więcej
Źródło :
The Prostate [Prostate] 2021 Jan; Vol. 81 (1), pp. 81-88. Date of Electronic Publication: 2020 Oct 06.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
DNA Helicases/*genetics
DNA-Binding Proteins/*genetics
Nuclear Proteins/*genetics
Prostate/*physiology
Prostatic Neoplasms/*genetics
Repressor Proteins/*genetics
Ubiquitin-Protein Ligase Complexes/*genetics
Animals ; DNA Damage ; Epithelial Cells/pathology ; Gene Expression ; Humans ; Male ; Mice ; Mice, Inbred C57BL ; Mice, Knockout ; Mutation ; Prostate/pathology ; Prostatic Hyperplasia/genetics ; Prostatic Hyperplasia/pathology ; Prostatic Neoplasms/pathology
Czasopismo naukowe
Tytuł :
Comparison of Biparametric and Multiparametric MRI for Clinically Significant Prostate Cancer Detection With PI-RADS Version 2.1.
Autorzy :
Tamada T; Department of Radiology, Kawasaki Medical School, Kurashiki, Japan.
Kido A; Department of Radiology, Kawasaki Medical School, Kurashiki, Japan.
Yamamoto A; Department of Radiology, Kawasaki Medical School, Kurashiki, Japan.
Takeuchi M; Department of Radiology, Radiolonet Tokai, Nagoya, Japan.
Miyaji Y; Department of Urology, Kawasaki Medical School, Kurashiki, Japan.
Moriya T; Department of pathology, Kawasaki Medical School, Kurashiki, Japan.
Sone T; Department of Radiology, Kawasaki Medical School, Kurashiki, Japan.
Pokaż więcej
Źródło :
Journal of magnetic resonance imaging : JMRI [J Magn Reson Imaging] 2021 Jan; Vol. 53 (1), pp. 283-291. Date of Electronic Publication: 2020 Jul 02.
Typ publikacji :
Journal Article
MeSH Terms :
Multiparametric Magnetic Resonance Imaging*
Prostatic Neoplasms*/diagnostic imaging
Humans ; Magnetic Resonance Imaging ; Male ; Reproducibility of Results ; Retrospective Studies
Czasopismo naukowe
Tytuł :
African-specific improvement of a polygenic hazard score for age at diagnosis of prostate cancer.
Autorzy :
Karunamuni RA; Department of Radiation Medicine and Applied Sciences, University of California San Diego, La Jolla, California, USA.
Huynh-Le MP; Department of Radiation Medicine and Applied Sciences, University of California San Diego, La Jolla, California, USA.
Fan CC; Healthlytix, San Diego, California, USA.
Thompson W; Department of Family Medicine and Public Health, University of California, San Diego, La Jolla, California, USA.
Eeles RA; The Institute of Cancer Research, London, UK.; Royal Marsden NHS Foundation Trust, London, UK.
Kote-Jarai Z; The Institute of Cancer Research, London, UK.
Muir K; Division of Population Health, Health Services Research and Primary Care, University of Manchester, Oxford Road, Manchester, M13 9PL, UK.; Division of Health Sciences, Warwick Medical School, University of Warwick, Coventry, UK.
Lophatananon A; Division of Population Health, Health Services Research and Primary Care, University of Manchester, Oxford Road, Manchester, M13 9PL, UK.
Tangen CM; SWOG Statistical Center, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Goodman PJ; SWOG Statistical Center, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Thompson IM Jr; CHRISTUS Santa Rosa Hospital-Medical Center, San Antonio, Texas, USA.
Blot WJ; Division of Epidemiology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.; International Epidemiology Institute, Rockville, Maryland, USA.
Zheng W; Division of Epidemiology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Kibel AS; Division of Urologic Surgery, Brigham and Womens Hospital, Boston, Massachusetts, USA.
Drake BF; Washington University School of Medicine, St. Louis, Missouri, USA.
Cussenot O; Sorbonne Universite, GRC n°5, AP-HP, Tenon Hospital, Paris, France.; CeRePP, Tenon Hospital, Paris, France.
Cancel-Tassin G; Sorbonne Universite, GRC n°5, AP-HP, Tenon Hospital, Paris, France.; CeRePP, Tenon Hospital, Paris, France.
Menegaux F; Université Paris-Saclay, UVSQ, Inserm, CESP, Villejuif, France.
Truong T; Université Paris-Saclay, UVSQ, Inserm, CESP, Villejuif, France.
Park JY; Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, Florida, USA.
Lin HY; School of Public Health, Louisiana State University Health Sciences Center, New Orleans, Louisiana, USA.
Bensen JT; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Fontham ETH; School of Public Health, Louisiana State University Health Sciences Center, New Orleans, Louisiana, USA.
Mohler JL; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.; Department of Urology, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA.
Taylor JA; Epidemiology Branch, National Institute of Environmental Health Sciences, North Carolina, USA.; Epigenetic and Stem Cell Biology Laboratory, National Institute of Environmental Health Sciences, North Carolina, USA.
Multigner L; Univ Rennes, Inserm, EHESP, Irset (Institut de recherche en santé, environnement et travail)-UMR_S 1085, Rennes, France.
Blanchet P; CHU de Pointe-à-Pitre, Univ Antilles, Univ Rennes, Inserm, EHESP, Irset (Institut de recherche en santé, environnement et travail)-UMR_S 1085, Pointe-à-Pitre, France.
Brureau L; CHU de Pointe-à-Pitre, Univ Antilles, Univ Rennes, Inserm, EHESP, Irset (Institut de recherche en santé, environnement et travail)-UMR_S 1085, Pointe-à-Pitre, France.
Romana M; UMR Inserm 1134 Biologie Intégrée du Globule Rouge, INSERM/Université Paris Diderot-Université Sorbonne Paris Cité/INTS/Université des Antilles, Paris, France.
Leach RJ; Department of Cell System and Anatomy and Mays Cancer Center, University of Texas Health San Antonio, San Antonio, Texas, USA.
John EM; Department of Medicine, Division of Oncology, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California, USA.
Fowke J; Department of Medicine and Urologic Surgery, Vanderbilt University Medical Center, 1211 Medical Center Drive, Nashville, Tennessee, USA.; Division of Epidemiology, Department of Preventive Medicine, The University of Tennessee Health Science Center, Tennessee, USA.
Bush WS; Case Western Reserve University, Department of Population and Quantitative Health Sciences, Cleveland Institute for Computational Biology, Cleveland, Ohio, USA.
Aldrich M; Department of Thoracic Surgery, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Crawford DC; Case Western Reserve University, Department of Population and Quantitative Health Sciences, Cleveland Institute for Computational Biology, Cleveland, Ohio, USA.
Srivastava S; Uniformed Services University, Bethesda, Maryland, USA.; Center for Prostate Disease Research, Bethesda, Maryland, USA.
Cullen JC; Uniformed Services University, Bethesda, Maryland, USA.; Center for Prostate Disease Research, Bethesda, Maryland, USA.
Petrovics G; Uniformed Services University, Bethesda, Maryland, USA.; Center for Prostate Disease Research, Bethesda, Maryland, USA.
Parent MÉ; Epidemiology and Biostatistics Unit, Centre Armand-Frappier Santé Biotechnologie, Institut national de la recherche scientifique, Quebec, Canada.; Department of Social and Preventive Medicine, School of Public Health, University of Montreal, Montreal, Quebec, Canada.
Hu JJ; Sylvester Comprehensive Cancer Center, The University of Miami School of Medicine, Miami, Florida, USA.
Sanderson M; Department of Family and Community Medicine, Meharry Medical College, Nashville, Tennessee, USA.
Mills IG; Center for Cancer Research and Cell Biology, Queen's University of Belfast, Belfast, UK.
Andreassen OA; NORMENT, KG Jebsen Centre, Oslo University Hospital and University of Oslo, Oslo, Norway.
Dale AM; Department of Radiology, University of California San Diego, La Jolla, California, USA.
Seibert TM; Department of Radiation Medicine and Applied Sciences, University of California San Diego, La Jolla, California, USA.; Department of Radiology, University of California San Diego, La Jolla, California, USA.
Pokaż więcej
Corporate Authors :
UKGPCS Collaborators
PRACTICAL Consortium; Institute of Cancer Research, Sutton, UK.
Źródło :
International journal of cancer [Int J Cancer] 2021 Jan 01; Vol. 148 (1), pp. 99-105. Date of Electronic Publication: 2020 Sep 24.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms :
Genetic Predisposition to Disease*
Models, Genetic*
Multifactorial Inheritance*
African Continental Ancestry Group/*statistics & numerical data
Prostatic Neoplasms/*epidemiology
African Continental Ancestry Group/genetics ; Age Factors ; Case-Control Studies ; Genotyping Techniques ; Humans ; Male ; Middle Aged ; Polymorphism, Single Nucleotide ; Proportional Hazards Models ; Prostatic Neoplasms/genetics
Czasopismo naukowe
Tytuł :
Association between CD8 and PD-L1 expression and outcomes after radical prostatectomy for localized prostate cancer.
Autorzy :
Vicier C; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medical Oncology, Institut Paoli-Calmettes, Aix Marseille University, Marseille, France.
Ravi P; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
Kwak L; Department of Biostatistics and Computational Biology, Dana Farber Cancer Institute, Boston, Massachusetts, USA.
Werner L; Department of Biostatistics and Computational Biology, Dana Farber Cancer Institute, Boston, Massachusetts, USA.
Huang Y; Department of Oncologic Pathology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
Evan C; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
Loda M; Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, New York, USA.
Hamid AA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
Sweeney CJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
Pokaż więcej
Źródło :
The Prostate [Prostate] 2021 Jan; Vol. 81 (1), pp. 50-57. Date of Electronic Publication: 2020 Sep 28.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
B7-H1 Antigen/*biosynthesis
CD8 Antigens/*biosynthesis
Prostatic Neoplasms/*immunology
B7-H1 Antigen/immunology ; CD3 Complex/biosynthesis ; CD3 Complex/immunology ; CD8 Antigens/immunology ; Cohort Studies ; Forkhead Transcription Factors/biosynthesis ; Forkhead Transcription Factors/immunology ; Humans ; Immunohistochemistry ; Male ; Middle Aged ; Neoplasm Metastasis ; Neoplasm Recurrence, Local/immunology ; Programmed Cell Death 1 Receptor/biosynthesis ; Programmed Cell Death 1 Receptor/immunology ; Proportional Hazards Models ; Prostatectomy ; Prostatic Neoplasms/surgery ; Retrospective Studies ; Tissue Array Analysis
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies